Drug Development & Delivery Magazine - Special Feature Bioavailability and Solubility
SPECIAL FEATURE – Bioavailability & Solubility: The Promise of Novel Ingredients
Contributor Cindy H. Dubin interviews Serán and several other leading companies, on how they are using novel ingredients to improve bioavailability & solubility challenges.
Serán’s VP Business Operations Rod Ketner discusses formulation strategies for developing large and complex small molecules with poor solubility and permeability. A hypothesis-driven approach helps formulators understand the barriers to absorption and sets the foundation for formulation approaches and dosage form architecture. Covering conventional strategies, spray dried dispersions and permeation enhancers, Dr. Ketner says an "outside-the-box approach is needed to address both solubility and permeability challenges.
Read on to learn more about Serán’s science-first, technology driven focus on turning complex molecules into medicines.
About Serán
Serán BioScience, LLC, is a science-driven Drug Development Partner, recognized as a world leader in drug development. Utilizing a foundation of physical and chemical science, Serán designs robust formulations and engineered solutions to some of the industry's toughest drug product problems. Our experience and background cover a wide range of pharmaceutical manufacturing concepts bringing our world-class expertise to you and your drug product. Serán’s team has decades of experience developing complex drug molecules into enabling medicines. With every addition to our team, we further our commitment to our clients’ success. From preclinical to GMP and beyond, Serán is here to support you and your drug product every step of the way.
For more information, visit www.Seranbio.com or email us at hello@seranbio.com.
Contact
Serán BioScience, LLC
63047 Layton Ave, Bend, OR 97701 USA
www.seranbio.com